We are looking for technical, scientific presentations from speakers who can share data and lessons learned from their oligonucleotide, peptide, mRNA, genome editing and drug delivery programs. Case studies of preclinical, clinical and CMC projects are highly desired. 

We are looking for presentations in the following topic areas:

  • Peptides for Rare Diseases; Novel Peptide Engineering and Peptide Chemistry
  • Oral Delivery of Peptides and Alternative Delivery Methods
  • Peptide-Based Vaccines; Cyclic Peptides
  • Theranostics/Radiopharmaceuticals/Tumor Imaging with Peptides
  • Oligos for CNS, Muscular/Cardiac, Immuno-oncology, Infectious, Inflammatory Disease
  • Synthesis of Long Oligos; Unconventional Methods of Making Oligos
  • Large Scale Manufacturing of Oligos, mRNA; ID & Control of Impurities in Manufacturing
  • Design, Synthesis & Manufacturing of Lipids for LNP Formulations
  • mRNA: Novel Tech, Vaccine/Non-Vaccine, (Pre-)Clinical Updates, Analytics, CMC, Synthesis, Formulation
  • RNA Editing, DNA editing (CRISPR-Cas), Base Editing; Genome Editing Tech and Therapeutics
  • Preclinical to Clinical/Translation Case Studies of Oligo, Peptide, mRNA, Genome Editing Programs
  • Regulatory CMC Strategies for mRNA Products, Oligos, Peptides & Other Molecules
  • Conjugations of Oligonucleotides and Peptides
  • Extra-Hepatic and Targeted Delivery in Oligos, Peptides, mRNAs and Other Modalities
  • Green Chemistries; Novel Chemistries; Novel Chemical Modifications
  • Analytics and Bioanalytics of Oligonucleotides, Peptides, mRNA: Characterization, QC methods
  • Funding/Investment and Market Trends in the Oligo, Peptide, mRNA, Genome Editing Fields
  • Diagnostic Applications Using Oligos, Peptide, mRNA

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

Call for Speakers

May 9-12
Boston, MA

Submit by Wednesday December 15th